Thank you, Chair, and I thank the witnesses for being here today.
Dr. Ouellette, I have two questions for you and then two questions for Mr. Sternthal.
In your statement, you said that CIHR's investments also allow researchers to examine protective practices against ticks and tick-borne diseases. Could you elaborate on what those protective practices are?
The second question is on your statement that “We have a better understanding of how this bacteria replicates, how it spreads in the bloodstream, how it evades destruction by the immune system, and how gene expression in the bacteria is regulated.”
Could you please elaborate on that as well?